Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma.

Audenet F, Isharwal S, Cha EK, Donoghue MTA, Drill EN, Ostrovnaya I, Pietzak EJ, Sfakianos JP, Bagrodia A, Murugan P, Dalbagni G, Donahue TF, Rosenberg JE, Bajorin DF, Arcila ME, Hechtman JF, Berger MF, Taylor BS, Al-Ahmadie H, Iyer G, Bochner BH, Coleman JA, Solit DB.

Clin Cancer Res. 2019 Feb 1;25(3):967-976. doi: 10.1158/1078-0432.CCR-18-2039. Epub 2018 Oct 23.

PMID:
30352907
2.

Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy.

Pietzak EJ, Zabor EC, Bagrodia A, Armenia J, Hu W, Zehir A, Funt S, Audenet F, Barron D, Maamouri N, Li Q, Teo MY, Arcila ME, Berger MF, Schultz N, Dalbagni G, Herr HW, Bajorin DF, Rosenberg JE, Al-Ahmadie H, Bochner BH, Solit DB, Iyer G.

Eur Urol. 2019 Feb;75(2):231-239. doi: 10.1016/j.eururo.2018.09.002. Epub 2018 Oct 2.

PMID:
30290956
3.

Histologic and Oncologic Outcomes Following Liver Mass Resection With Retroperitoneal Lymph Node Dissection in Patients With Nonseminomatous Germ Cell Tumor.

Pietzak EJ, Assel M, Becerra MF, Tennenbaum D, Feldman DR, Bajorin DF, Motzer RJ, Bosl GJ, Carver BS, Sjoberg DD, Sheinfeld J.

Urology. 2018 Aug;118:114-118. doi: 10.1016/j.urology.2018.04.009. Epub 2018 Apr 25.

PMID:
29704586
4.

Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer.

Lee SH, Hu W, Matulay JT, Silva MV, Owczarek TB, Kim K, Chua CW, Barlow LJ, Kandoth C, Williams AB, Bergren SK, Pietzak EJ, Anderson CB, Benson MC, Coleman JA, Taylor BS, Abate-Shen C, McKiernan JM, Al-Ahmadie H, Solit DB, Shen MM.

Cell. 2018 Apr 5;173(2):515-528.e17. doi: 10.1016/j.cell.2018.03.017.

PMID:
29625057
5.

Genomic Profile of Urothelial Carcinoma of the Upper Tract from Ureteroscopic Biopsy: Feasibility and Validation Using Matched Radical Nephroureterectomy Specimens.

Bagrodia A, Audenet F, Pietzak EJ, Kim K, Murray KS, Cha EK, Sfakianos JP, Iyer G, Singla N, Arcila M, Bochner BH, Al-Ahmadie HA, Solit DB, Coleman JA.

Eur Urol Focus. 2018 Jan 30. pii: S2405-4569(18)30006-3. doi: 10.1016/j.euf.2018.01.005. [Epub ahead of print]

PMID:
29396293
6.

Male Neobladder.

Pietzak EJ, Donahue TF, Bochner BH.

Urol Clin North Am. 2018 Feb;45(1):37-48. doi: 10.1016/j.ucl.2017.09.003. Review.

PMID:
29169449
7.

Incidence and Effect of Thromboembolic Events in Radical Cystectomy Patients Undergoing Preoperative Chemotherapy for Muscle-invasive Bladder Cancer.

Bagrodia A, Sukhu R, Winer AG, Levy E, Vacchio M, Lee B, Pietzak EJ, Donahue TF, Cha E, Iyer G, Sjoberg DD, Vickers AJ, Rosenberg JE, Bajorin DF, Dalbagni G, Bochner BH.

Clin Genitourin Cancer. 2017 Aug 10. pii: S1558-7673(17)30232-X. doi: 10.1016/j.clgc.2017.07.022. [Epub ahead of print]

8.

Prognostic Value of TERT Alterations, Mutational and Copy Number Alterations Burden in Urothelial Carcinoma.

Isharwal S, Audenet F, Drill E, Pietzak EJ, Iyer G, Ostrovnaya I, Cha E, Donahue T, Arcila M, Jayakumaran G, Berger MF, Rosenberg JE, Bajorin DF, Coleman J, Dalbagni G, Reuter VE, Bochner BH, Solit DB, Al-Ahmadie HA.

Eur Urol Focus. 2017 Aug 10. pii: S2405-4569(17)30189-X. doi: 10.1016/j.euf.2017.07.004. [Epub ahead of print]

9.

The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy.

Li Q, Assel M, Benfante NE, Pietzak EJ, Herr HW, Donat M, Cha EK, Donahue TF, Bochner BH, Dalbagni G.

Eur Urol Focus. 2019 Jan;5(1):104-108. doi: 10.1016/j.euf.2017.06.013. Epub 2017 Jun 27.

PMID:
28753857
10.

Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets.

Pietzak EJ, Bagrodia A, Cha EK, Drill EN, Iyer G, Isharwal S, Ostrovnaya I, Baez P, Li Q, Berger MF, Zehir A, Schultz N, Rosenberg JE, Bajorin DF, Dalbagni G, Al-Ahmadie H, Solit DB, Bochner BH.

Eur Urol. 2017 Dec;72(6):952-959. doi: 10.1016/j.eururo.2017.05.032. Epub 2017 Jun 3.

11.

The Impact of Blue Light Cystoscopy on the Diagnosis and Treatment of Bladder Cancer.

Pietzak EJ.

Curr Urol Rep. 2017 May;18(5):39. doi: 10.1007/s11934-017-0685-8. Review.

PMID:
28324275
12.

Editorial Comment.

Pietzak EJ, Becerra MF, Sheinfeld J.

Urology. 2017 Apr;102:162. doi: 10.1016/j.urology.2016.08.064. Epub 2016 Dec 26. No abstract available.

PMID:
28034529
13.

Editorial Comment.

Pietzak EJ, Becerra MF, Sheinfeld J.

Urology. 2017 Jan;99:173. doi: 10.1016/j.urology.2016.04.062. Epub 2016 Nov 7. No abstract available.

PMID:
27829530
14.

Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors.

Bagrodia A, Lee BH, Lee W, Cha EK, Sfakianos JP, Iyer G, Pietzak EJ, Gao SP, Zabor EC, Ostrovnaya I, Kaffenberger SD, Syed A, Arcila ME, Chaganti RS, Kundra R, Eng J, Hreiki J, Vacic V, Arora K, Oschwald DM, Berger MF, Bajorin DF, Bains MS, Schultz N, Reuter VE, Sheinfeld J, Bosl GJ, Al-Ahmadie HA, Solit DB, Feldman DR.

J Clin Oncol. 2016 Nov 20;34(33):4000-4007. doi: 10.1200/JCO.2016.68.7798. Epub 2016 Sep 30.

15.

Neoadjuvant Treatment of High-Risk, Clinically Localized Prostate Cancer Prior to Radical Prostatectomy.

Pietzak EJ, Eastham JA.

Curr Urol Rep. 2016 May;17(5):37. doi: 10.1007/s11934-016-0592-4. Review.

PMID:
26968417
16.

Simplification of the Fuhrman grading system for renal cell carcinoma.

Smith ZL, Pietzak EJ, Meise CK, Van Arsdalen K, Wein AJ, Malkowicz SB, Guzzo TJ.

Can J Urol. 2015 Dec;22(6):8069-73.

PMID:
26688135
17.

Reply.

Pietzak EJ, Mucksavage P, Guzzo TJ, Malkowicz SB.

Urology. 2015 Nov;86(5):973. doi: 10.1016/j.urology.2015.05.044. Epub 2015 Sep 26. No abstract available.

PMID:
26414726
18.

Single instillation of mitomycin C plus bacillus Calmette-Guérin (BCG) versus BCG alone in high grade non-muscle invasive bladder cancer.

Weiss BE, Pietzak EJ, Wein AJ, Malkowicz SB, Guzzo TJ.

Can J Urol. 2015 Aug;22(4):7876-81.

PMID:
26267025
19.

Heavy Cigarette Smoking and Aggressive Bladder Cancer at Initial Presentation.

Pietzak EJ, Mucksavage P, Guzzo TJ, Malkowicz SB.

Urology. 2015 Nov;86(5):968-72. doi: 10.1016/j.urology.2015.05.040. Epub 2015 Jul 17.

PMID:
26190088
20.

Histology of Testicular Biopsies Obtained for Experimental Fertility Preservation Protocol in Boys with Cancer.

Pietzak EJ 3rd, Tasian GE, Tasian SK, Brinster RL, Carlson C, Ginsberg JP, Kolon TF.

J Urol. 2015 Nov;194(5):1420-4. doi: 10.1016/j.juro.2015.04.117. Epub 2015 May 30.

21.

Outcomes of radical cystectomy in potential candidates for bladder preservation therapy.

Pietzak EJ, Sterling ME, Smith ZL, Malkowicz SB, Guzzo TJ.

Urology. 2015 Apr;85(4):869-75. doi: 10.1016/j.urology.2015.01.001. Epub 2015 Feb 11.

PMID:
25681831
22.

Impact of race on selecting appropriate patients for active surveillance with seemingly low-risk prostate cancer.

Pietzak EJ, Van Arsdalen K, Patel K, Malkowicz SB, Wein AJ, Guzzo TJ.

Urology. 2015 Feb;85(2):436-40. doi: 10.1016/j.urology.2014.09.065.

PMID:
25623715
23.

The presence of high-grade prostatic intraepithelial neoplasia or atypia on prostate biopsy does not adversely affect prostatectomy outcomes for patients otherwise eligible for active surveillance.

Pietzak EJ 3rd, Kabarriti AE, Mucksavage P, Bavaria T, Van Arsdalen K, Malkowicz SB, Wein AJ, Guzzo TJ.

Urology. 2014 Dec;84(6):1442-7. doi: 10.1016/j.urology.2014.04.066. Epub 2014 Oct 5.

PMID:
25288572
24.

Factors influencing the length of stay after radical cystectomy: implications for cancer care and perioperative management.

Pietzak EJ, Hwang WT, Malkowicz SB, Guzzo TJ.

Ann Surg Oncol. 2014 Dec;21(13):4383-9. doi: 10.1245/s10434-014-3877-1. Epub 2014 Jul 22.

PMID:
25047468
25.

Multiple repeat prostate biopsies and the detection of clinically insignificant cancer in men with large prostates.

Pietzak EJ, Resnick MJ, Mucksavage P, Van Arsdalen K, Wein AJ, Malkowicz SB, Guzzo TJ.

Urology. 2014 Aug;84(2):380-5. doi: 10.1016/j.urology.2014.04.029. Epub 2014 Jun 12.

PMID:
24929944
26.

Does quantification of smoking history correlate with initial bladder tumor grade and stage?

Pietzak EJ, Malkowicz SB.

Curr Urol Rep. 2014 Jul;15(7):416. doi: 10.1007/s11934-014-0416-3.

PMID:
24832198
27.

Advancements in laparoscopic partial nephrectomy: expanding the feasibility of nephron-sparing.

Pietzak EJ, Guzzo TJ.

Adv Urol. 2012;2012:148952. doi: 10.1155/2012/148952. Epub 2012 May 9.

Supplemental Content

Loading ...
Support Center